BR112020016020A8 - Inibidor de atr e aplicação do mesmo - Google Patents
Inibidor de atr e aplicação do mesmoInfo
- Publication number
- BR112020016020A8 BR112020016020A8 BR112020016020A BR112020016020A BR112020016020A8 BR 112020016020 A8 BR112020016020 A8 BR 112020016020A8 BR 112020016020 A BR112020016020 A BR 112020016020A BR 112020016020 A BR112020016020 A BR 112020016020A BR 112020016020 A8 BR112020016020 A8 BR 112020016020A8
- Authority
- BR
- Brazil
- Prior art keywords
- application
- same
- atr inhibitors
- atr
- atr inhibitor
- Prior art date
Links
- 239000003112 inhibitor Substances 0.000 title abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Abstract
A presente invenção refere-se a um composto como um inibidor de ATR e uma aplicação na preparação de um fármaco como um inibidor de ATR. Em particular, é descrito um composto representado pela fórmula (I) ou um isômero ou sal farmaceuticamente aceitável do mesmo.
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810124494 | 2018-02-07 | ||
| CN201810124494.2 | 2018-02-07 | ||
| CN201811361512 | 2018-11-15 | ||
| CN201811361512.5 | 2018-11-15 | ||
| PCT/CN2019/074578 WO2019154365A1 (zh) | 2018-02-07 | 2019-02-02 | 一种atr抑制剂及其应用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BR112020016020A2 BR112020016020A2 (pt) | 2020-12-08 |
| BR112020016020A8 true BR112020016020A8 (pt) | 2023-04-25 |
Family
ID=67548753
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112020016020A BR112020016020A8 (pt) | 2018-02-07 | 2019-02-02 | Inibidor de atr e aplicação do mesmo |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US11434232B2 (pt) |
| EP (1) | EP3753937B1 (pt) |
| JP (1) | JP7290651B2 (pt) |
| CN (1) | CN111712499B (pt) |
| AU (1) | AU2019217388C1 (pt) |
| BR (1) | BR112020016020A8 (pt) |
| CA (1) | CA3090330A1 (pt) |
| DK (1) | DK3753937T3 (pt) |
| FI (1) | FI3753937T3 (pt) |
| HR (1) | HRP20240161T1 (pt) |
| IL (1) | IL276489A (pt) |
| LT (1) | LT3753937T (pt) |
| PL (1) | PL3753937T3 (pt) |
| PT (1) | PT3753937T (pt) |
| RS (1) | RS65147B1 (pt) |
| SG (1) | SG11202007485PA (pt) |
| SI (1) | SI3753937T1 (pt) |
| WO (1) | WO2019154365A1 (pt) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112047938B (zh) * | 2019-06-06 | 2022-11-22 | 北京泰德制药股份有限公司 | 作为atr激酶抑制剂的2,4,6-三取代的嘧啶化合物 |
| JP2022543856A (ja) * | 2019-08-06 | 2022-10-14 | ウーシー・バイオシティ・バイオファーマシューティクス・カンパニー・リミテッド | Ａｔｒ阻害剤の結晶形及びその使用 |
| WO2021233376A1 (zh) * | 2020-05-20 | 2021-11-25 | 北京泰德制药股份有限公司 | 作为atr激酶抑制剂的2,4,6-三取代的嘧啶化合物 |
| KR20230012586A (ko) * | 2020-05-29 | 2023-01-26 | 썬전 링팡 바이오테크 컴퍼니 리미티드 | 플루오로 피롤로 피리딘계 화합물 및 이의 용도 |
| BR112022026205A2 (pt) * | 2020-06-24 | 2023-03-14 | Astrazeneca Uk Ltd | Produto farmacêutico, uso de um conjugado anticorpo anti-her2-fármaco ou um inibidor de atr na fabricação de um medicamento, e, método de tratamento do câncer |
| AU2021302146A1 (en) * | 2020-07-03 | 2023-01-19 | Antengene Discovery Limited | ATR inhibitors and uses thereof |
| CN116178366A (zh) * | 2021-11-26 | 2023-05-30 | 深圳市瓴方生物医药科技有限公司 | 氟代吡啶并吡咯类化合物的晶型及其制备方法 |
| WO2023131234A1 (en) * | 2022-01-06 | 2023-07-13 | Shanghai Antengene Corporation Limited | Crystalline forms of an atr inhibitor |
| WO2023215133A1 (en) * | 2022-05-02 | 2023-11-09 | AcuraStem Incorporated | Pikfyve kinase inhibitors |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009093981A1 (en) * | 2008-01-23 | 2009-07-30 | S Bio Pte Ltd | Triazine compounds as kinase inhibitors |
| GB2465405A (en) | 2008-11-10 | 2010-05-19 | Univ Basel | Triazine, pyrimidine and pyridine analogues and their use in therapy |
| US20110053923A1 (en) | 2008-12-22 | 2011-03-03 | Astrazeneca | Chemical compounds 610 |
| SA111320519B1 (ar) | 2010-06-11 | 2014-07-02 | Astrazeneca Ab | مركبات بيريميدينيل للاستخدام كمثبطات atr |
| WO2012101654A2 (en) | 2011-01-25 | 2012-08-02 | Sphaera Pharma Pvt. Ltd | Novel triazine compounds |
| AR095443A1 (es) | 2013-03-15 | 2015-10-14 | Fundación Centro Nac De Investig Oncológicas Carlos Iii | Heterociclos condensados con acción sobre atr |
| TWI700283B (zh) | 2014-08-04 | 2020-08-01 | 德商拜耳製藥公司 | ２-(嗎啉-４-基)-１,７-萘啶 |
| WO2019050889A1 (en) * | 2017-09-08 | 2019-03-14 | Bluevalley Pharmaceutical Llc | SUBSTITUTED PYRROLOPYRIDINES AS ATR INHIBITORS |
-
2019
- 2019-02-02 SG SG11202007485PA patent/SG11202007485PA/en unknown
- 2019-02-02 CN CN201980012249.5A patent/CN111712499B/zh active Active
- 2019-02-02 LT LTEPPCT/CN2019/074578T patent/LT3753937T/lt unknown
- 2019-02-02 AU AU2019217388A patent/AU2019217388C1/en active Active
- 2019-02-02 EP EP19750376.6A patent/EP3753937B1/en active Active
- 2019-02-02 PL PL19750376.6T patent/PL3753937T3/pl unknown
- 2019-02-02 JP JP2020542631A patent/JP7290651B2/ja active Active
- 2019-02-02 PT PT197503766T patent/PT3753937T/pt unknown
- 2019-02-02 HR HRP20240161TT patent/HRP20240161T1/hr unknown
- 2019-02-02 WO PCT/CN2019/074578 patent/WO2019154365A1/zh active Application Filing
- 2019-02-02 CA CA3090330A patent/CA3090330A1/en active Pending
- 2019-02-02 US US16/968,429 patent/US11434232B2/en active Active
- 2019-02-02 BR BR112020016020A patent/BR112020016020A8/pt unknown
- 2019-02-02 SI SI201930708T patent/SI3753937T1/sl unknown
- 2019-02-02 DK DK19750376.6T patent/DK3753937T3/da active
- 2019-02-02 RS RS20240129A patent/RS65147B1/sr unknown
- 2019-02-02 FI FIEP19750376.6T patent/FI3753937T3/fi active
-
2020
- 2020-08-04 IL IL276489A patent/IL276489A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2019217388B2 (en) | 2023-11-09 |
| EP3753937B1 (en) | 2024-01-10 |
| PT3753937T (pt) | 2024-02-06 |
| FI3753937T3 (fi) | 2024-01-31 |
| WO2019154365A1 (zh) | 2019-08-15 |
| RU2020128324A3 (pt) | 2022-03-09 |
| AU2019217388A1 (en) | 2020-09-03 |
| RU2020128324A (ru) | 2022-03-09 |
| AU2019217388C1 (en) | 2024-03-07 |
| US20200399260A1 (en) | 2020-12-24 |
| CN111712499A (zh) | 2020-09-25 |
| CN111712499B (zh) | 2023-06-02 |
| JP2021512908A (ja) | 2021-05-20 |
| EP3753937A1 (en) | 2020-12-23 |
| BR112020016020A2 (pt) | 2020-12-08 |
| DK3753937T3 (da) | 2024-02-12 |
| CA3090330A1 (en) | 2019-08-15 |
| SG11202007485PA (en) | 2020-09-29 |
| PL3753937T3 (pl) | 2024-04-02 |
| HRP20240161T1 (hr) | 2024-04-12 |
| US11434232B2 (en) | 2022-09-06 |
| IL276489A (en) | 2020-09-30 |
| EP3753937A4 (en) | 2021-07-07 |
| RS65147B1 (sr) | 2024-02-29 |
| SI3753937T1 (sl) | 2024-03-29 |
| LT3753937T (lt) | 2024-02-26 |
| JP7290651B2 (ja) | 2023-06-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112020016020A8 (pt) | Inibidor de atr e aplicação do mesmo | |
| CY1120635T1 (el) | Βενζαμιδια αμινοετεροαρυλιου ως αναστολεις κινασης | |
| PH12016502382A1 (en) | Substituted indazole compounds as irak4 inhibitors | |
| PH12018500041A1 (en) | Substituted aza compoounds as irak-4 inhibitors | |
| AR110381A2 (es) | Inhibidores biarilo de tirosina cinasa de bruton | |
| CL2016002970A1 (es) | Sales de adición de (s)-2-(1-(6-amino-5-cianopirimidin-4-ilamino)etil)-4-oxo-3-fenil-3,4-dihidropirrolo[1,2-f][1,2,4]triazina-5-carbonitrilo. | |
| PH12018501099A1 (en) | Novel biphenyl compound or salt thereof | |
| EA201890307A1 (ru) | Индазольные и азаиндазольные соединения как ингибиторы irak-4 | |
| BR112017019286A2 (pt) | composto de fórmula (i) ou um sal farmaceuticamente aceitável deste | |
| BR112018003026A2 (pt) | composições compreendendo um inibidor de pi3k e um inibidor de hdac | |
| BR112019024785A2 (pt) | composto de bifenila ou sal do mesmo, composição farmacêutica, agente antineoplásico e uso | |
| CL2017002179A1 (es) | Sales de inhibidor de pi3k y procesos de preparación | |
| BR112015018738A8 (pt) | compostos de tetra-hidropirrolotiazina, seus usos, e composição farmacêutica | |
| BR112020008664A8 (pt) | Composto macrocíclico que atua como inibidor de weel e aplicações do mesmo | |
| BR112016011755A2 (pt) | derivado de ureia ou sal farmacologicamente aceitável do mesmo | |
| MA40059A (fr) | Inhibiteurs de la phosphatidylinositol 3-kinase | |
| AR103680A1 (es) | Inhibidores selectivos de bace1 | |
| CL2020001752A1 (es) | Derivado de oxi-fluoropiperidina como inhibidor de quinasa. | |
| UY36875A (es) | Composiciones inhibidoras de bromodominios para el tratamiento de diversas enfermedades | |
| BR112017011316A2 (pt) | derivados heterocíclicos e uso destes | |
| BR112017016817A2 (pt) | derivados heterocíclicos formilados como inibidores de fgfr4 | |
| BR112014008555A2 (pt) | r(+)-n-formil-propargil-aminoindano | |
| BR112017008794A2 (pt) | inibidores de di-heteroaril histona desacetilase e seu uso em terapia | |
| BR112019003710A2 (pt) | inibidor de pde7, composto, composição farmacêutica, uso de um inibidor de pde7 ou de um composto, e, método para tratar ou prevenir uma doença que é melhorada pela inibição de pde7. | |
| BR112020008258B8 (pt) | Compostos de biarila substituída ou seus sais farmaceuticamente aceitáveis, sua composição e seu uso como inibidores de indoleamina 2,3-dioxigenase (ido) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B350 | Update of information on the portal [chapter 15.35 patent gazette] | ||
| B25A | Requested transfer of rights approved |
Owner name: WUXI BIOCITY BIOPHARMACEUTICS CO., LTD. (CN) |
|
| B06W | Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette] |